Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial
van der Ree, Meike H, MD, de Vree, J Marleen, MD, Stelma, Femke, MD, Willemse, Sophie, MD, van der Valk, Marc, MD, Rietdijk, Svend, MD, Molenkamp, Richard, PhD, Schinkel, Janke, MD, van Nuenen, Ad C, BSc, Beuers, Ulrich, Prof, Hadi, Salah, MD, Harbers, Marten, PhD, van der Veer, Eva, MSc, Liu, Kai, PhD, Grundy, John, PhD, Patick, Amy K, PhD, Pavlicek, Adam, PhD, Blem, Jacqueline, BSc, Huang, Michael, MD, Grint, Paul, MD, Neben, Steven, PhD, Gibson, Neil W, PhD, Kootstra, Neeltje A, PhD, Reesink, Hendrik W, Dr
Published in The Lancet (British edition) (18.02.2017)
Published in The Lancet (British edition) (18.02.2017)
Get full text
Journal Article